Barts Health NHS Trust v CG (by his Litigation Friend the Official solicitor)

Neutral Citation Number[2026] EWCOP 55 (T3)

View download options

Barts Health NHS Trust v CG (by his Litigation Friend the Official solicitor)

Neutral Citation Number[2026] EWCOP 55 (T3)

Neutral Citation Number: [2026] EWCOP 55 (T3)

COP No: 20040870

IN THE COURT OF PROTECTION

Royal Courts of Justice

Strand, London, WC2A 2LL

Date: 16 October 2026

Before:

MRS JUSTICE THEIS DBE

Between:

Barts Health NHS Trust

Applicant

- and -

CG (by his Litigation Friend the Official solicitor)

Respondent

James Berry KC (instructed by Hill Dickinson) for the Applicant

David Lawson (instructed by the Official Solicitor) for the Respondent

Hearing date: 16 October 2026

Approved Judgment

.............................

This judgment was delivered in public but a transparency order is in force. The judge has given leave for this version of the judgment to be published on condition that (irrespective of what is contained in the judgment) in any published version of the judgment the anonymity of CG must be strictly preserved. All persons, including representatives of the media and legal bloggers, must ensure that this condition is strictly complied with. Failure to do so may be a contempt of court.

Mrs Justice Theis DBE:

Introduction

1.

The court today is dealing with an application by Barts Health NHS Trust (the Trust), dated 13 October 2026, seeking declarations in the Court of Protection in relation to a 59-year-old man, CG, that he lacks capacity in connection with these proceedings and the proposed medical treatment, including any deprivation of liberty, is authorised as being in his best interests.

2.

The court is very grateful for the great care and preparation undertaken in this case by the respective clinical and legal teams. This hearing has been able to take place today due to the high-quality of the documents provided to the court, including the position statements from Mr Berry KC and Mr Lawson, and the witness statement from the clinicians. It makes an enormous difference to have those detailed documents available to the court at such short notice. That skilled preparation has enabled this hearing to take place within a matter of days after the application was made and for this court to give an ex tempore judgment today.

3.

The declarations sought concerning capacity and the proposed treatment for pituitary macroadenoma in respect of CG are as follows:

(a)

A declaration that CG lacks capacity to make decisions regarding medical treatment. 

(b)

The court is asked to declare that it is in CG’s best interests to undergo a keyhole procedure called an endoscopic transsphenoidal pituitary tumour resection, under general anaesthetic. The clinicians for the Trust have formed the clear conclusion that CG requires that procedure and the associated pre-operative and post-operative care, all of which is set out in detail within the treatment plan contained in the bundle. 

(c)

The other declaration sought concerns the treatment plan and the Trust seeks authorisation of any deprivation of liberty arising from its implementation. 

4.

The proposed procedure is scheduled to take place on 20 October 2026. There was an earlier scheduled date, but it was decided there should be an application to court and an IMCA appointed to support CG. If the procedure does not take place next Tuesday, there will be a delay of at least three weeks before another theatre slot becomes available. This is a specialist procedure undertaken by a specialist team.

5.

CG is represented in these proceedings by the Official Solicitor. I have considered the submissions made on her behalf by Mr David Lawson. The Official Solicitor considers that the proposed treatment is in CG's best interests. Whilst there is a risk of post-operative complications, there is an immediate risk of deterioration in CG's vision if the procedure is not undertaken within the proposed timetable. The Official Solicitor's position is that those risks outweigh the risks associated with the operation itself.

6.

CG has been an inpatient at the hospital since the end of August 2026. He has a large pituitary macroadenoma which is significantly impacting upon his vision and affecting his endocrine function. The detailed statement filed by the treating clinicians sets out a clear medical analysis over recent weeks and explains how the clinical decision to recommend surgery has been reached.

7.

The Official Solicitor's representative had the opportunity to visit CG in hospital yesterday and has filed a detailed statement. In essence, CG’s position remains that he objects to the proposed procedure.

Capacity

8.

There is no issue between the parties that CG lacks capacity to make this decision and to conduct these proceedings. The COP3 sets out a summary of his diagnosis of paranoid schizophrenia and records that he has lived in supported living accommodation for approximately 25 years.

9.

In relation to capacity, the evidence can be summarised as follows. CG has a fixed belief that there is nothing wrong with him and that he simply needs new glasses. His diagnosis has been explained to him on multiple occasions. Dr G explained the diagnosis to him twice and, on both occasions, CG was unable to recall it shortly afterwards. He has been reviewed by a number of doctors. The evidence demonstrates a longstanding impairment of mind and the existence of fixed delusional beliefs, including the belief that there is nothing wrong with him.

10.

In relation to the statutory framework, the court must consider section 3 of the Mental Capacity Act 2005 (MCA 2005). It is clear that CG does not understand the relevant information and is not able to retain, use or weigh that information. Taking account of the COP3, the IMCA’s visit and the Official Solicitor's representative's visit yesterday, I am satisfied that CG lacks capacity to make the relevant decisions before the court.

Background

11.

Turning to the background to this application, in 2014 CG was admitted to hospital with a reduced level of consciousness, fever and seizures. An MRI scan completed on 24 February 2014 demonstrated a 15mm x 11mm pituitary lesion consistent with a pituitary macroadenoma.

12.

CG's pituitary function was assessed and was normal other than low testosterone levels. He was discharged from hospital on 27 February 2014. An outpatient appointment was arranged for August 2014 and an endocrine appointment for November 2014. CG attended neither.

13.

CG thereafter failed to engage with follow-up appointments. During 2023 and 2025 it was noted that his vision had deteriorated. He failed to attend follow-up appointments in 2026 and there was also deterioration in his mental state. It was reported that he had stopped taking prescribed medication.

14.

CG was admitted to hospital on 28 August 2026. Subsequent MRI imaging confirmed that the tumour had grown significantly and was causing severe compression of the optic pathway, invading the right cavernous sinus and exerting mass effect on the right temporal lobe. It measured 27 x 39 x 33mm. Ophthalmological assessment on 3 September 2026 demonstrated visual impairment affecting both eyes.

15.

The case was discussed at a multidisciplinary team meeting and the conclusion reached was that surgery was indicated. A capacity assessment undertaken on 17 September 2026 concluded that CG lacked capacity. Dr G rightly considered that an IMCA should be appointed. Following a short delay, the IMCA was able to meet with CG on 29 September 2026 and with the treating team. Following that the IMCA supported the proposed surgery.

16.

On 9 October 2026 a further multidisciplinary meeting involving all relevant disciplines was convened. The conclusion of that meeting was that the proposed treatment should proceed. This application was made on 13 October 2026.

Evidence

17.

The joint clinical statement by Dr G, Consultant in Diabetes, Endocrinology and Acute Medicine, and Dr P, Consultant Neurosurgeon, describes a debulking procedure, namely a keyhole operation undertaken through the nasal passage, intended to reduce and remove as much of the tumour as possible. This is the established procedure in this situation.

18.

The evidence outlines the risks of not proceeding with surgery.

19.

First, progressive visual deterioration. CG’s visual impairment is already significant. In relation to the left eye, CG is unable to see fingers and that position is unlikely to change. In relation to the right eye, his vision is approximately 6/12 and surgery may improve vision or, at least, will arrest further deterioration.

20.

The second risk concerns the tumour's effect upon hormone production.

21.

Thirdly, there is a risk of further cranial nerve dysfunction and obstructive hydrocephalus, which would require emergency surgery and potentially giving rise to fatal consequences.

22.

On the other side of the balance sheet, the risks of surgery are set out in the evidence. They include risks relating to cortisol deficiency, diabetes insipidus, loss of smell, CSF leak and the risks inherent in any surgical procedure.

23.

A further risk in this case arises from CG’s opposition to treatment and the possibility that restraint or chemical sedation may be required. Those matters are addressed within the treatment plan.

Best Interests

24.

Looking at best interests, the court is guided by section 4 of the Mental Capacity Act and the guidance given in Aintree University Hospitals NHS Trust v James [2013] UKSC 67; [2014] 591. Lady Hale observed at paragraph 22 that:

“... in considering the best interests of this particular patient at this particular time, decision-makers must look at his welfare in the widest sense, not just medical but social and psychological; they must consider the nature of the medical treatment in question, what it involves and its prospects of success; they must consider what the outcome of that treatment for the patient is likely to be; they must try and put themselves in the place of the individual patient and ask what his attitude to the treatment is or would be likely to be; and they must consult others who are looking after him or interested in his welfare, in particular for their view of what his attitude would be.”

25.

As has been set out in the Trust's position statement, there are three options: first, to undertake the procedure; secondly, monitoring; and thirdly, to do nothing. I agree with Mr Berry that, realistically, only two options are available in this case given CG's history of non-compliance with monitoring arrangements.

26.

The risks of not proceeding have already been set out. They include serious consequences, namely progressive deterioration in visual function, particularly in relation to his right eye (where deterioration could be arrested or visual function improved). Importantly, this tumour has been present since 2014 and by 2026 has grown with significant consequences. Those risks are likely to continue and to have a substantial impact on CG’s quality of life.

27.

The risks of the proposed surgery need to be weighed carefully. CG has consistently refused the procedure. However, that refusal arises from his fixed belief that he does not have a tumour and that his difficulties can be cured by obtaining a new pair of glasses.

28.

Having considered the evidence I am clear that CG’s best interests are served by making the necessary declarations to permit the procedure to take place. This procedure is the standard treatment option, and CG should be placed in no worse position due to his lack of capacity than anybody else requiring this procedure.

29.

Turning to the care plan and the implementation of restraint both pre-operatively and post-operatively, I have carefully considered the plan. It includes measures which are likely to be a deprivation of liberty, although that will depend upon the level of resistance shown by CG. The plan takes great care to identify all of the steps that should be taken in relation to the procedure. If those steps are unsuccessful, it may be necessary for him to be sedated before being taken to theatre.

30.

The post-operative period is the stage at which restraint and deprivation of liberty are most likely to arise. The treatment plan refers to matters including nasal packing, the use of a catheter and venous and arterial access and the importance of maintaining these. It is anticipated that CG will remain in the intensive care unit for approximately five to seven days for intensive clinical monitoring. This is a specialist setting and the clinicians there are experienced in managing situations involving restraint, if required.

31.

I am satisfied that it is in Cg’s best interests for the court to approve this care and treatment plan and to authorise any deprivation of liberty that is required. I am sure that the Trust will do everything it can to minimise any restrictions, and restraint is only to be used where necessary and proportionate in the particular circumstances arising.

32.

Mr Berry, on behalf of the Trust, has apologised for the delay in bringing the application and referred me to the Birmingham and Solihull Mental Health NHS Foundation Trust v CG [2026] EWCOP 37 and the factors set out at paragraph 67 that should be considered by a Trust in deciding whether an application should be made to the court. In particular, he referred to sub-paragraph (3), where a patient objects to the proposed treatment plan. I agree with Mr Berry that this sub-paragraph applied, particularly in view of the proposed restraint both pre-operatively and post-operatively. It was therefore right for this application to be made.

33.

For all of those reasons, I have reached the decision that CG lacks capacity and that it is in his best interests for the proposed surgical procedure to take place. I approve the care plan and authorise the deprivation of liberty in the circumstances described.

Document download options

Download PDF (104.9 KB)

The original format of the judgment as handed down by the court, for printing and downloading.

Download XML

The judgment in machine-readable LegalDocML format for developers, data scientists and researchers.